stockportfolio.pro
Stocks / MRNA vs VEEV
MRNA vs VEEV
Moderna, Inc. and Veeva Systems Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
VEEV is the larger company ($25.2B vs $24.5B). On the fundamentals, MRNA grows revenue faster (19.3% vs 16.9%); VEEV earns a higher net margin (28.4% vs -145.2%); VEEV has the stronger return on equity (12.6% vs -32.6%). Full numbers below — the stronger figure on each row is in green.
| Moderna, Inc. (MRNA) | Veeva Systems Inc. (VEEV) | |
|---|---|---|
| Market cap | $24.5B | $25.2B |
| Revenue (latest FY) | $1.94B | $3.20B |
| Net income (latest FY) | $-2.82B | $908.91M |
| Revenue growth (5y CAGR) | 19.3% | 16.9% |
| Net margin | -145.2% | 28.4% |
| Return on equity | -32.6% | 12.6% |
| P/E ratio | — | 27.5 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 2 | 10 |
| Positive free cash flow | No | — |
Compare with another company:
See the full MRNA vs VEEV breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open MRNA's full financials → Open VEEV's full financials →More comparisons
Frequently asked questions
Which is bigger, MRNA or VEEV?
Veeva Systems Inc. is larger by market capitalization — $25.2B versus $24.5B.
Which grows faster, MRNA or VEEV?
Over the last five fiscal years, Moderna, Inc. grew revenue faster — 19.3%/yr versus 16.9%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.